Ensemble, améliorons la qualité en santé

Transparency Committe Opinion

HUMIRA

Date 28 May 2008
Pharmaceutical
formulation

HUMIRA 40 mg, solution for injection in pre-filled syringe
Pack of 2 x 0.8 ml glass syringes with two alcohol pads (CIP: 362 230-5)
HUMIRA 40 mg, solution for injection in pre-filled pen
Pack of 2 x 0.8 ml pens with 2 alcohol pads (CIP: 378 014-5)

ATC code
  1. L04AB04
Active ingredient

adalimumab

Laboratory / Manufacturer ABBOTT
Reason for request Inclusion on the list of medicines reimbursed by National Insurance and approved for use by hospitals in the extension of indication “treatment of moderate to severe chronic plaque psoriasis in adult patients who failed to respond to or who have a contraindication to, or are intolerant to other systemic therapy including cyclosporine, methotrexate or PUVA”.

Contacts

Contact évaluation des médicaments